Direct Oral Anticoagulants versus Low Molecular Weight Heparin for Venous Thromboembolism in Cancer Patients: An Updated Systematic Review and Meta-Analysis

被引:0
|
作者
Akbar, Usman
Mughal, Ahmad Kabir
Khan, Ahmad Ali
Umer, Ahmed Muaaz
Malik, Saad U.
Shamshad, Talha
Ali, Ahmed
Shafique, Nouman
Danish, Ali
Anwar, Rana Usman
Rasool, Muhammad Wajid
机构
关键词
Anticoagulation;
D O I
10.1161/circ.148.suppl_1.17843
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A17843
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Efficacy and Safety of Rivaroxaban Versus Low Molecular Weight Heparin for Treating Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis
    Shrestha, Abhigan
    Mainali, Nischal
    Shrestha, Sajina
    Jaiswal, Vikash
    Rajak, Kripa
    Edara, Ravi Sankar Reddy
    Anil, K. C.
    CIRCULATION, 2024, 150
  • [22] Efficacy and Safety of Apixaban versus Low Molecular Weight Heparin for the Treatment of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis
    Shrestha, Abhigan Babu B.
    Mainali, Nischal
    Shrestha, Shubham
    Jaiswal, Vikash
    Shrestha, Sajina
    Adhikari, Ashok
    Chapagain, Sanskriti
    Shrestha, Shumneva
    Sedhai, Yub Raj
    Rijal, Rishikesh
    Karki, Bikash
    Bhattarai, Suju
    Nuruzzaman, Md.
    CIRCULATION, 2023, 148
  • [23] Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
    Mulder, Frits, I
    Bosch, Floris T. M.
    Young, Annie M.
    Marshall, Andrea
    McBane, Robert D.
    Zemla, Tyler J.
    Carrier, Marc
    Kamphuisen, Pieter Willem
    Bossuyt, Patrick M. M.
    Buller, Harry R.
    Weitz, Jeffrey, I
    Middeldorp, Saskia
    van Es, Nick
    BLOOD, 2020, 136 (12) : 1433 - 1441
  • [24] Assessment of venous thromboembolism treatment in patients with cancer on low molecular weight heparin, warfarin, and the direct oral anticoagulants
    Uppuluri, Ellen M.
    Burke, Kelly R.
    Haaf, Christina Mactal
    Shapiro, Nancy L.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (02) : 261 - 268
  • [25] Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: A systematic review and meta-analysis: Comment
    Dufrost, Virginie
    Wahl, Denis
    Zuily, Stephane
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (06) : 1006 - 1007
  • [26] Direct Oral Anticoagulants Compared to Low Molecular Weight Heparin in the Treatment of Cancer-Associated Thromboembolism: An Updated Meta-Analysis of Randomized Controlled Trails
    Wongsaengsak, Sariya
    Ball, Somedeb
    Khandelwal, Nuvneet
    Tikue, Alay
    Motes, Arunee
    Jahan, Nusrat
    Thein, Kyaw Zin
    Tijani, Lukman
    BLOOD, 2019, 134
  • [27] Risk of Recurrent Venous Thromboembolism and Bleeding in Cancer Patients Treated With Direct Oral Anticoagulants Versus Low-molecular-weight Heparin
    Long, Brit
    Koyfman, Alex
    Gottlieb, Michael
    ACADEMIC EMERGENCY MEDICINE, 2020, 27 (02) : 170 - 172
  • [28] Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients A Systematic Review and Meta-analysis
    Tran, Alexandre
    Fernando, Shannon M.
    Carrier, Marc
    Siegal, Deborah M.
    Inaba, Kenji
    Vogt, Kelly
    Engels, Paul T.
    English, Shane W.
    Kanji, Salmaan
    Kyeremanteng, Kwadwo
    Lampron, Jacinthe
    Kim, Dennis
    Rochwerg, Bram
    ANNALS OF SURGERY, 2022, 275 (01) : 19 - 28
  • [29] Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis
    Zhou, Hong
    Chen, Ting-Ting
    Ye, Ling-ling
    Ma, Jun-Jie
    Zhang, Jin-Hua
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [30] Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis
    Hong Zhou
    Ting-Ting Chen
    Ling-ling Ye
    Jun-Jie Ma
    Jin-Hua Zhang
    World Journal of Surgical Oncology, 22